Detour(R) Unveils Snack Size Protein Bar (tes so delicious your taste buds are goi...)

Detour(R) Unveils Snack Size Protein Bar

Date:4/22/2008

tes so delicious your taste buds are going to demand more. Luckily, that same award-winning taste is available in our larger bars, too."

The snack size bars are available at GNC retailers or online at http://detourbar.com. Distribution is expected to be broadened in the coming months.

About The Detour Caramel Peanut Bars

The Detour(R) Caramel Peanut(TM) bar is made with whey protein and is available in three sizes -- 43 grams, 85 grams and the new 20 gram snack size. Their award-winning candy bar taste makes them the #1 whey protein bar on the market.

About Forward Foods

Forward Foods, LLC manufactures and markets high protein, snack, and energy bars under the Detour brand. Since the introduction of the original bar in October 2002, Detour has grown into a $50MM retail brand platform and is the leading high protein brand in health and fitness stores. Detour revolutionized the high protein bar category by being the first to utilize candy bar technology and formulation to create a truly "great tasting" high protein bar. The brand has now expanded to more mainstream channels including food grocery, drug store, mass merchant, club and convenience stores. For more information on the complete line of great tasting, high protein Detour products, visit http://detourbar.com

SOURCE Detour
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Nations Vending Industry Unveils New Health Oriented Vending Program:
2. Qforma Unveils Managed Care Optimization Solution for Pharma Marketing Executives
3. CVS Caremark Charity Classic Golf Tournament Unveils 10th Anniversary Field
4. UHW Unveils Proposals for SEIU Convention
5. Advancing Interoperability - Nonin(R) Medical Unveils Worlds First Bluetooth(R)-Enabled, Wireless Fingertip Pulse Oximeter
6. AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM)
7. Registry unveils real-world data on novel excel stent
8. LA Career Coach Unveils LifeStage Methodology to Help Individuals Make Effective Work-Life Choices
9. Video: TI unveils industrys first family of complete analog front ends for superior ultrasound systems
10. Hazelden Publishing Unveils Valuable New Resource for Women Seeking Recovery From Addiction
11. Genetic research unveils common origins for distinct clinical diagnoses

Post Your Comments:

(Date:7/24/2008)...July 24 /PRNewswire-USNewswire/ -- Steven Mosher,...I), says that America has,a hidden problem of sex ...feminists refuse to address., In PRI,s latest You...,East and South Asian countries, of sex-selective ...actice has already claimed the lives of over 100,m...

(Date:7/24/2008)...July 24 /PRNewswire/ -- A new alliance of animal,l...roblems -- obesity -- in,pets and pet owners., Am...ne third of us are,obese, including 9 million chil...ok like us -- mirror us with similar health issues...partnership that includes,Harvard Medical Center, ...

(Date:7/24/2008)... CosmetaLife clinical trial results could lead ...cost-effective treatment for deep lines and wrinkl...inn. (PRWEB) July 24, 2008 -- Gel-Del Technologie...company announced that it has concluded clinical t...at company officials say holds potential to be a m...

(Date:7/24/2008)...RNewswire-FirstCall/ --, Key Highlights, Misys p...ns and is now,raising targets for the next phase o...) of GBP492m up 6%, bringing Group operating profi...xecuting on its strategy and entering,into the nex...m for growth., To view the Multimedia News Releas...

Breaking Medicine News(10 mins):Health News:PRI: Pro-Life Leader Blames Feminist Groups for Slaughter of Girls 2 Health News:PetFit Challenge Helps Keep Pets - and Pet Owners - Healthy 2 Health News:Clinical Trial Concluded For New Wrinkle Treatment 2 Health News:Clinical Trial Concluded For New Wrinkle Treatment 3 Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2 Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3 Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4

[0] PRI: Pro-Life Leader Blames Feminist Groups for Slaughter of Girls [0] PetFit Challenge Helps Keep Pets - and Pet Owners - Healthy [0] Clinical Trial Concluded For New Wrinkle Treatment [0] Misys Announces Preliminary Results for the Year Ended 31 May 2008

...g blind and partially sighted people in the Lothia...e for the Blind (RNIB) received a ?25,000 donation...help in launching the charity's Positive Steps pro...ning for people preparing to enter employment. Th...

... for Type 2 Diabetes appears to have a twin benefi...ar under control// but also helps them to lose wei...n associate Professor with the Royal Prince Alfred...this drug has been under trial on patient voluntee...

... of teeth, do not improve the mental well being an...study//. Thousands of children have orthodontic wo...n the dental profession that braces or orthodontic...ll-being, reported the online edition of BBC News....

...cer deaths for the second consecutive year, the Am...can Health Challenge// to educate and motivate Ame... Many Americans are concerned about potentially d...t 50 percent of cancer deaths could be prevented t...

Other Medicine News:Health News:Healthy Behaviors Can Prevent at Least 50 Percent of Cancer Deaths 2

RNIB Receives ?25,000 to Help Blin Diabetic Patients Get a Reprieve Dental Braces Do Not Improve Self-esteem: Study Healthy Behaviors Can Prevent at Least 50 Percent of Cancer Deaths

(Date:7/23/2008)...Dendreon Corporation,(Nasdaq: DNDN ) today announ...g Committee (IDMC) to review in October 2008 the i...e Company,s Phase 3 IMPACT (IMmunotherapy,for Pros...B) clinical trial,of PROVENGE(R) (sipuleucel-T). P...llular immunotherapy for the treatment of advanced...

(Date:7/22/2008)...t Initiative bring MJFF,s,current active industry ...09, NEW YORK, July 22 /PRNewswire-USNewswire/ -- ...ormative treatments and a cure for Parkinson,s,dis...s Research has awarded,$2.7 million in total fundi... granted under MJFF,s Therapeutics Development Ini...

(Date:7/22/2008)...e to Patients of Passing a Follow-...ly 22 /- Insmed Inc. (Nasda... biopharmaceuticals, today,announced that Geoffrey...ngressional briefing on Friday, July 25th, 2008 to...approval pathway for follow-on,biologics (FOB) and...

(Date:7/22/2008)...re-FirstCall/ -- NicOx S.A.,(Euronext Paris: COX) ...enrollment of 417 osteoarthritis (OA) patients wit...logy studies in the United States, in line with,pr...igned to assess the,blood pressure profile of napr...using the Ambulatory Blood Pressure Monitoring (AB...

[0] Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October [0] Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics [0] Insmed CEO to Present at Congressional Briefing on Follow-On Biologics [0] NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients

... for New Aggrastat Study in American Heart Journal... Inc. (TSX:MPH;,Amex:MCU), a cardiovascular focuse... the two-year, follow-up results from the,STRATEGY...luting,Stent Versus Abciximab and Bare Metal Stent...hed in the July edition of the Journal,of the Amer...

...LD, Conn., July 11, 2007 /PRNewswire/ -- Phase 3 r...hat oral dabigatran,etexilate once daily, administ...o enoxaparin, also administered for an average of ...) and all-cause,mortality after total hip replacem...ding associated with dabigatran etexilate was,simi...

Other Medicine Technology:Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 2 Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 3 Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 4 Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 5 Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 2 Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 3 Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 4 Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 5

Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis

The GENESIS II* Total Knee System will define the state of knee implants.

Cruciate Retaining, Posterior Stabilized and Constrained Components.

StelKast's Proven knee system is a long term, quality solution based on a clinically proven design. Available in both posterior stabilized and anatomically correct cruciate retaining configurations.

The Balanced Knee System provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results.

Medicine Products:

GENESIS II* Total Knee System Ascent Primary Knee System Proven Cruciate Retaining Knee System Balanced Knee System

Detour(R) Unveils Snack Size Protein Bar(tes so delicious your taste buds are goi...),Health